Tag: Polyarteritis nodosa

Before the advent of effective treatment, polyarteritis nodosa (PAN) was often fatal within months. The first line treatment for polyarteritis nodosa is highly dependent on disease severity and is primarily centered around immunosuppressive therapy to control the destructive inflammation of medium-sized blood vessels. This article provides a comprehensive overview of the treatment approaches for PAN, from initial induction to long-term remission management.

Polyarteritis nodosa (PAN), a potential meaning for the acronym 'PPAN', is a rare disease with an estimated annual incidence of 3 to 4 cases per 100,000 people in the United States [1.3.8]. While 'PPAN' is not a standard medical abbreviation, it likely refers to either **Polyarteritis Nodosa (PAN)** or **Peripheral Parenteral Nutrition (PPN)**.